Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers

Drug Testing and Analysis

Volumn 6, Issue 10, 2014, Pages 1002-1010

  Newmeyer, Matthew N ^a,b   Desrosiers, Nathalie A ^a,b   Lee, Dayong ^a,b,c   Mendu, Damodara R ^a,d   Barnes, Allan J ^a   Gorelick, David A ^a,e   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Cannabinoids; Oral fluid; Oral Eze

Indexed keywords

DRUG PRODUCTS; MEDICINE;

CANNABINOIDS; COLLECTION DEVICE; CUT-OFFS; DETECTION TIME; DETECTION WINDOWS; DRUG TESTING; ILLICIT DRUG; MATRIX; ORAL FLUIDS; ORAL-EZE®;

CONTROLLED DRUG DELIVERY;

BUFFER; CANNABINOID; TETRAHYDROCANNABINOL; DRONABINOL;

ADULT; ARTICLE; CANNABIS SMOKING; CLINICAL ARTICLE; DEVICES; ELUTION; FEMALE; FLUID INTAKE; GAS CHROMATOGRAPHY; GOVERNMENT; HUMAN; MALE; MASS SPECTROMETRY; PERFORMANCE; PRIORITY JOURNAL; SMOKING; UNITED STATES; VALIDATION STUDY; CHEMISTRY; EPIDEMIOLOGY; MASS FRAGMENTOGRAPHY; METABOLISM; PROCEDURES; SALIVA; SUBSTANCE ABUSE; TIME FACTOR; YOUNG ADULT;

ADULT; CANNABINOIDS; DRONABINOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MARIJUANA SMOKING; SALIVA; SUBSTANCE ABUSE DETECTION; TIME FACTORS; YOUNG ADULT;

EID: 84916886448     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1632     Document Type: Article

References (26)

1. W.M. Bosker, M.A. Huestis. Oral fluid testing for drugs of abuse. Clin. Chem. 2009, 55, 1910.
2. 9-THC concentration in serum and oral fluid: Limits of impairment. Drug Alcohol Depen. 2006, 85, 114.
3. 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 2004, 28, 394.
4. N.A. Desrosiers, A.J. Barnes, R.L. Hartman, K.B. Scheidweiler, E.A. Kolbrich-Spargo, D.A. Gorelick, R.S. Goodwin, M.A. Huestis. Oral fluid and plasma 3, 4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Anal. Bioanal. Chem. 2013, 405, 4067.
5. M.A. Huestis, E.J. Cone. Methamphetamine disposition in oral fluid, plasma, and urine. Ann. NY Acad. Sci. 2007, 1098, 104.
6. M.A. Huestis, A. Verstraete, T.C. Kwong, J. Morland, M.J. Vincent, R. de la Torre. Oral-fluid testing: Promises and pitfalls. Clin. Chem. 2011, 57, 805.
7. United Nations Office on Drugs and Crime. World Drug Report 2012. Available at: http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf [Novemeber 2013].
8. Substance Abuse and Mental Health Services Administration. Results from the 2011 national survey on drug use and health: Summary of national findings. Available at: http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.pdf [Novemeber 2013].
9. J.H. Lacey, T. Kelley-Baker, D. Furr-Holden, R.B. Voas, E. Romano, A. Ramirez, K. Brainard, C. Moore, P. Torres, A. Berning. 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results. Available at: http://www.cicad.oas.org/apps/Document.aspx?Id=998 [Novemeber 2013].
10. R.S. Niedbala, K.W. Kardos, D.F. Fritch, S. Kardos, T. Fries, J. Waga, J. Robb, E.J. Cone. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol. 2001, 25, 289.
11. D. Lee, G. Milman, A.J. Barnes, R.S. Goodwin, J. Hirvonen, M.A. Huestis. Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin. Chem. 2011, 57, 1127.
12. D. Lee, G. Milman, D.M. Schwope, A.J. Barnes, D.A. Gorelick, M.A. Huestis. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin. Chem. 2012, 58, 1101.
13. 9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J. Anal. Toxicol. 2010, 34, 216.
14. 9-tetrahydrocannabinol in serum and oral fluid. J. Anal. Toxicol. 2007, 31, 288.
15. D. Lee, D.M. Schwope, G. Milman, A.J. Barnes, D.A. Gorelick, M.A. Huestis. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin. Chem. 2012, 58, 748.
16. 9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J. Anal. Toxicol. 2006, 30, 409.
17. G. Milman, D.M. Schwope, D.A. Gorelick, M.A. Huestis. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin. Chim. Acta 2012, 413, 765.
18. Substance Abuse and Mental Health Services Administration. Proposed revisions to the mandatory guidelines for federal workplace drug testing programs. Fed. Regist. 2004, 69, 19673.
19. G. Milman, A.J. Barnes, R.H. Lowe, M.A. Huestis. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J. Chromatogr. A 2010, 1217, 1513.
20. H. Gjerde, P.T. Normann, A. Christophersen. The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume. J. Anal. Toxicol. 2010, 34, 416.
21. K. Langel, C. Engblom, A. Pehrsson, T. Gunnar, K. Ariniemi, P. Lillsunde. Drug testing in oral fluid-evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32, 393.
22. M.M. Bergamaschi, E.L. Karschner, R.S. Goodwin, K.B. Scheidweiler, J. Hirvonen, R.H. Queiroz, M.A. Huestis. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin. Chem. 2013, 59, 519.
23. J. Ramaekers, G. Kauert, E. Theunissen, S. Toennes, M. Moeller. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J. Psychopharmacol. 2009, 23, 266.
24. C. Moore, C. Coulter, D. Uges, J. Tuyay, S. van der Linde, A. van Leeuwen, M. Garnier, J. Orbita Jr. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci. Int. 2011, 212, 227.
25. G. Milman, A.J. Barnes, D.M. Schwope, E.W. Schwilke, W.D. Darwin, R.S. Goodwin, D.L. Kelly, D.A. Gorelick, M.A. Huestis. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin. Chem. 2010, 56, 1261.
26. G. Milman, A. Barnes, D. Schwope, E. Schwilke, R. Goodwin, D. Kelly, D. Gorelick, M. Huestis. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Anal. Bioanal. Chem. 2011, 401, 599.